Gene · 6700
Papers1,491
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,491
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis. | BMC Cancer | 2022 | 36344947 | PubTator, text mining | PubMed |
| Exosome-encapsulated ncRNAs: Emerging yin and yang of tumor hallmarks. | Front Genet | 2022 | 36338993 | PubTator, text mining | PubMed |
| Acute anxiety during the COVID-19 pandemic was associated with higher levels of everyday altruism. | Sci Rep | 2022 | 36329157 | PubTator, text mining | PubMed |
| Smoking modulates different secretory subpopulations expressing SARS-CoV-2 entry genes in the nasal and bronchial airways. | Sci Rep | 2022 | 36307504 | PubTator, text mining | PubMed |
| Influence of trip distance and population density on intra-city mobility patterns in Tokyo during COVID-19 pandemic. | PLoS One | 2022 | 36306314 | PubTator, text mining | PubMed |
| Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis. | Front Oncol | 2022 | 36300102 | PubTator, text mining | PubMed |
| (+)-Usnic Acid and Its Derivatives as Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses. | Viruses | 2022 | 36298709 | PubTator, text mining | PubMed |
| Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery. | Pharmaceuticals (Basel) | 2022 | 36297381 | PubTator, text mining | PubMed |
| Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients. | Int J Mol Sci | 2022 | 36293478 | PubTator, text mining | PubMed |
| Non-Coding RNAs Are Implicit in Chronic Myeloid Leukemia Therapy Resistance. | Int J Mol Sci | 2022 | 36293127 | PubTator, text mining | PubMed |
| A retrospective study of prevalence and pattern of international consensus on ANA patterns among patients with hepatitis C virus infection. | PeerJ | 2022 | 36275455 | PubTator, text mining | PubMed |
| Urine stabilization and normalization strategies favor unbiased analysis of urinary EV content. | Sci Rep | 2022 | 36271135 | PubTator, text mining | PubMed |
| Biomarkers of gastric cancer: current advancement. | Heliyon | 2022 | 36247151 | PubTator, text mining | PubMed |
| Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment. | J Nanobiotechnology | 2022 | 36242076 | PubTator, text mining | PubMed |
| Corneal epithelium in keratoconus underexpresses active NRF2 and a subset of oxidative stress-related genes. | PLoS One | 2022 | 36240204 | PubTator, text mining | PubMed |
| Small extracellular vesicles as a multicomponent biomarker platform in urinary tract carcinomas. | Front Mol Biosci | 2022 | 36237572 | PubTator, text mining | PubMed |
| Increasing the Efficiency of the Accumulation of Recombinant Proteins in Plant Cells: The Role of Transport Signal Peptides. | Plants (Basel) | 2022 | 36235427 | PubTator, text mining | PubMed |
| Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021. | Int J Mol Sci | 2022 | 36232692 | PubTator, text mining | PubMed |
| MiR-522-3p Targets Transcription Factor 4 to Overcome Cisplatin Resistance of Gastric Cells. | J Oncol | 2022 | 36204179 | PubTator, text mining | PubMed |
| Beyond darunavir: recent development of next generation HIV-1 protease inhibitors to combat drug resistance. | Chem Commun (Camb) | 2022 | 36200462 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6700/papers?page=10